Margarida Azevedo, MSc,  —

Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.

Articles by Margarida Azevedo

Total Immature Red Blood Cell Count May Be Significant in Sickle Cell Anemia and Important Therapeutic Target

Researchers investigated how the levels of reticulocytosis, the increase of circulating immature red blood cells, correlated with increased hospitalizations and cerebrovascular pathologies in pediatric patients with sickle cell anemia (SCA) receiving chronic transfusion therapy (CTT). According to the findings, in this group of children with SCA, cerebrovascular pathology at initiation…

Catastrophizing Pain by Parents of Sickle Cell Youth Linked to Lowered Quality of Life

Researchers at the Emory University School of Medicine examined the effects of protective parenting and parent catastrophizing in the quality of life and functional disability of adolescents dealing with  chronic pain associated with sickle cell anemia. Catastophizing refers to over protective parenting that sometimes inteferes with a maturing child’s social, developmental and…